We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
PennyMac Financial
PFSI
$3.93B
| $245K | ﹤0.01% |
14,414
+800
| +6% | +$14.2K |
|
|
MN
2727
DELISTED
MANNING & NAPIER, INC.
MN
| $245K | ﹤0.01% |
18,860
+600
| +3% | +$7.24K |
|
2728
Corcept Therapeutics
CORT
$11.7B
| $243K | ﹤0.01% |
43,475
+10,100
| +30% | +$36.6K |
|
|
CYTR
2729
DELISTED
CytRx Corp
CYTR
| $243K | ﹤0.01% |
12,005
+933
| +8% | +$17.4K |
|
2730
HEICO Corp Class A
HEI.A
$36.9B
| $242K | ﹤0.01% |
11,919
| – | – |
|
|
TREC
2731
DELISTED
Trecora Resources
TREC
| $242K | ﹤0.01% |
19,843
+2,700
| +16% | +$37.1K |
|
2732
Johnson Outdoors
JOUT
$501M
| $241K | ﹤0.01% |
7,290
+300
| +4% | +$9.32K |
|
2733
Shinhan Financial Group
SHG
$34.8B
| $241K | ﹤0.01% |
6,451
+151
| +2% | +$5.9K |
|
|
TLGT
2734
DELISTED
Teligent, Inc
TLGT
| $240K | ﹤0.01% |
2,942
+600
| +26% | +$57.9K |
|
|
NAVB
2735
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $240K | ﹤0.01% |
7,563
+1,220
| +19% | +$41.3K |
|
|
AVHI
2736
DELISTED
A V Homes, Inc.
AVHI
| $240K | ﹤0.01% |
15,017
+800
| +6% | +$12.1K |
|
|
FSYS
2737
DELISTED
FUEL SYSTEMS SOLUTIONS INC COM STK
FSYS
| $240K | ﹤0.01% |
21,704
+900
| +4% | +$9.76K |
|
2738
Build-A-Bear
BBW
$434M
| $239K | ﹤0.01% |
12,155
+1,000
| +9% | +$20.5K |
|
2739
Destination XL Group
DXLG
$31M
| $239K | ﹤0.01% |
48,370
+3,000
| +7% | +$14.8K |
|
2740
Vitamin Cottage Natural Grocers
NGVC
$738M
| $239K | ﹤0.01% |
8,645
+1,350
| +19% | +$38.4K |
|
|
HALL
2741
DELISTED
Hallmark Financial Services, Inc.
HALL
| $239K | ﹤0.01% |
2,253
+90
| +4% | +$9.96K |
|
|
NUTR
2742
DELISTED
Nutraceutical International Co
NUTR
| $239K | ﹤0.01% |
12,125
+600
| +5% | +$11.3K |
|
|
CACB
2743
DELISTED
Cascade Bancorp
CACB
| $239K | ﹤0.01% |
49,874
+2,100
| +4% | +$10K |
|
|
BCOV
2744
DELISTED
Brightcove, Inc.
BCOV
| $237K | ﹤0.01% |
32,317
+6,100
| +23% | +$47.1K |
|
|
MTEM
2745
DELISTED
Molecular Templates, Inc.
MTEM
| $237K | ﹤0.01% |
354
+86
| +32% | +$56.6K |
|
|
JMBA
2746
DELISTED
Jamba, Inc.
JMBA
| $237K | ﹤0.01% |
16,078
+2,100
| +15% | +$32.1K |
|
|
ZVO
2747
DELISTED
Zovio Inc. Common Stock
ZVO
| $236K | ﹤0.01% |
24,458
+1,100
| +5% | +$11.1K |
|
|
WIFI
2748
DELISTED
Boingo Wireless, Inc.
WIFI
| $236K | ﹤0.01% |
31,240
+1,600
| +5% | +$12.4K |
|
|
CARB
2749
DELISTED
Carbonite Inc
CARB
| $236K | ﹤0.01% |
16,536
+2,800
| +20% | +$40.7K |
|
|
EPE
2750
DELISTED
EP Energy Corporation
EPE
| $236K | ﹤0.01% |
22,558
+5,400
| +31% | +$56.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.